Mammalian embryos develop in a low oxygen environment. The transcription factor hypoxia inducible factor 1a (HIF1α) is a key element in the cellular response to hypoxia. Complete deletion of Hif1α from the mouse conceptus causes extensive placental, vascular and heart defects, resulting in embryonic lethality. However the precise role of Hif1α in each of these organ systems remains unknown. To further investigate, we conditionally-deleted Hif1α from mesoderm, vasculature and heart individually. Surprisingly, deletion from these tissues did not recapitulate the same severe heart phenotype or embryonic lethality. Placental insufficiency, such as occurs in the complete Hif1α null, results in elevated cellular hypoxia in mouse embryos. We hypothesized that subjecting the Hif1α conditional null embryos to increased hypoxic stress might exacerbate the effects of tissue-specific Hif1α deletion. We tested this hypothesis using a model system mimicking placental insufficiency. We found that the majority of embryos lacking Hif1α in the heart died when exposed to non-physiological hypoxia. This was a heart-specific phenomenon, as HIF1α protein accumulated predominantly in the myocardium of hypoxia-stressed embryos. Our study demonstrates the vulnerability of the heart to lowered oxygen levels, and that under such conditions of non-physiological hypoxia the embryo absolutely requires Hif1α to continue normal development. Importantly, these findings extend our understanding of the roles of Hif1α in cardiovascular development.
Introduction
The hypoxia inducible factor 1 (HIF1) is a key element in the cell's response to hypoxia. It is a heterodimeric transcription factor consisting of HIF1α and aryl hydrocarbon receptor nuclear translocator (ARNT). HIF1 affects processes as broad as angiogenesis, inflammation, epithelial to mesenchymal transition, metabolism, differentiation, proliferation and apoptosis (Eisinger-Mathason et al., 2013; Eltzschig and Carmeliet, 2011; Lendahl et al., 2009; Prabhakar and Semenza, 2012; Schlaeger et al., 1997) . In cell culture, HIF1α has a half-life of o5 min at a PO 2 of 140 mmHg (20% oxygen) (Wang et al., 1995) . HIF1α has enhanced stability and activity when cellular PO 2 falls below 42 mmHg, with a half maximal response at 10.5 mmHg and a maximal response at 3.5 mmHg (Jiang et al., 1996; Lando et al., 2002a Lando et al., , 2002b . Compared with adults, mammalian embryos develop in a low oxygen environment (physiological hypoxia). At sea level the partial pressure of oxygen (PO 2 ) is $ 155 mmHg with oxygen comprising 21% of air, but adult tissue PO 2 levels are reported to range widely, with direct measurement techniques detecting the highest levels in lung tissue and the lowest levels in the superficial skin (reviewed in Carreau et al., 2011; Land, 2004) . During gestation, human maternal arterial and venous PO 2 are around half that of air, and low oxygen tensions are a feature of the gestational environment from conception ($ 55 mmHg) through embryo implantation and early placentation (0-13 mmHg). Even in late gestation, where placental gas exchange facilitates oxygen delivery to the fetus, the PO 2 values for the umbilical artery and vein are $ 30% that of the respective maternal values. Cellular PO 2 can also be measured indirectly using nitroimidazole derivatives such as pimonidazole hydrochloride (hypoxyprobe™, Raleigh et al., 1999) . Such techniques have revealed that tissues in different regions of the mouse embryo have a PO 2 of r10 mmHg at a variety of stages of development (Dunwoodie, 2009; Lee et al., 2001; Ream et al., 2008) .
A number of studies report the effects of loss of Hif1α in mice, but evidence suggests that the story may not be so simple. Firstly, it is accepted that Hif1α is essential for normal mouse embryo development and survival (Compernolle et al., 2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998) . However, complete deletion of Hif1α from the mouse conceptus causes extensive placental and cardiovascular defects, resulting in elevated cellular hypoxia, and lethality by embryonic day (E) 10.5. Here, the lack of placental formation creates a hypoxic environment for embryogenesis. Therefore, we do not know the specific roles of Hif1α in cardiovascular development during normal embryogenesis; that is embryogenesis under conditions of physiological hypoxia with a functioning placenta. It is possible that Hif1α is required equally for the development of the placenta, vasculature and heart, and that these three interdependent systems develop in parallel. Alternatively, Hif1α might have a primary function in only one of these systems, which then impacts on the development of the others. Secondly, conditional deletion of Hif1α indicates roles in bone development, and in adult mice roles in angiogenesis and heart function Kisanuki et al., 2001; Tang et al., 2004) . Moreover, during the course of our study, additional roles for Hif1α have been indicated in development of the limb, heart and hematopoietic system (Amarilio et al., 2007; Imanirad et al., 2013; Krishnan et al., 2008; Provot et al., 2007) . However, incomplete deletion of Hif1α and other factors (see Discussion) also suggests that we still do not have a clear understanding of its role during cardiovascular development.
Here we address the specific role(s) of Hif1α in development of the heart and vasculature of the mouse by deleting Hif1α from these systems individually, using a floxed Hif1α allele and Cre recombinase technology. Surprisingly, deletion of Hif1α from these tissues individually did not recapitulate the same severe cardiovascular phenotype or embryonic lethality as seen in complete Hif1α null conceptuses. This indicates that Hif1a is not required for development of the heart or vasculature under normal conditions. We further demonstrate that there is a strong Gene-environment interaction occurring in this system, whereby elevated cellular hypoxia, such as occurs in the complete Hif1α null due to placental insufficiency, exacerbated the effects of Hif1α deletion. In these experiments, the majority of embryos lacking Hif1α in the heart died when exposed to nonphysiological hypoxia. This appeared to be a heart-specific phenomenon, as nuclear HIF1α protein accumulated predominantly in the myocardium of hypoxia-stressed embryos. We conclude that of all the tissues in the developing mouse embryo, the heart is the most susceptible to gestational hypoxia, and that Hif1α expression in the developing heart is crucial for embryo survival under such hypoxic conditions.
Methods

Mouse lines and genotyping
This research was performed following the guidelines, and with the approval, of the Garvan Institute of Medical Research/St. Vincent's Animal Experimentation Ethics Committee, research approvals 09/33 and 12/33. Mouse lines carrying targeted alleles and randomly inserted transgenes used in these studies are as follows:
Tek-Cre [Tg(Tek-cre)12Flv] (Koni et al., 2001) ; (Saga et al., 1999) ; Hif1α flox [Hif1α tm3Rsjo ] (Ryan et al., 2000) ; and Hif1α Δ [Hif1α tm3.1Rsjo ]
These mouse lines were all backcrossed for a minimum of ten generations into the C57BL/6J genetic background, and were maintained on this background.
Nkx2-5 IRESCre [Nkx2-5 tm2(cre)Rph ] (Stanley et al., 2002) . For this line, mice were maintained on a 129/SvJ;SJL;C57BL/6J hybrid genetic background.
Mice and embryos were genotyped by PCR using the following primers:
Cre 5 0 -CATTTGGGCCAGCTAAACAT-3 0 and 5′-ATTCTCCCACCGTCAGTACG-3 0 Hif1α Δ 5 0 -TGGGGATGAAAACATCTGCT-3 0 and 5 0 -GCAGTTAA-GAGCACTAGTTG-3 0 Hif1α flox 5 0 -GCTAAGGAAGTAAGCACCTGGA-3 0 and 5 0 -TCGAC-GTTCAGAACTCATCCT-3 0 Embryos and placentas were collected at various stages of development, and were weighed and genotyped.
Heart morphology analysis
Heart morphology of all conditionally deleted embryos (Hif1α Δ/flox Cre þ / À ) was assessed using wax sectioning. To increase throughput, about half of control embryos were initially screened by magnetic resonance imaging (MRI). All defects visualized by MRI were subsequently wax sectioned for confirmation. The remaining control embryos were wax sectioned without prior MRI analysis. For wax sectioning, whole E17.5 embryos were fixed in Bouin's solution overnight, the heart-lung complex manually dissected, and 7 μm frontal sections (with respect to the heart)
were cut and stained with haematoxylin and eosin by standard methods. For MRI, whole E17.5 embryos were fixed in either Bouin's solution or 4% paraformaldehyde in PBS, then two embryos set in tubes in 4% agarose gel containing a Gadoliniumbased contrast agent (2 mM Gadopentetate dimeglumine, Bayer). The embryos were stored at 4 1C prior to MRI and were imaged within 7 days of preparation. High resolution ex vivo MRI images were acquired using a vertical bore 9.4T magnet (Oxford Instruments) interfaced to a Biospec Bruker spectrometer running ParaVision 5.1 (Bruker). A shielded gradient system with a maximum gradient strength of 548 mTesla/m and a rise time of 160 μs was used (Magnex Scientific). The resonator for all experiments was a 15 mm birdcage coil (m2m Imaging Corp.). 3D gradient echo images (3DGE) T1-weighted images were acquired using a protocol similar to that previously described at an isotropic voxel resolution of 35 μm (Schneider et al., 2003) . Rosset et al., 2004) . Data were initially viewed in the axial plane, then were reformatted using oblique cuts in the 3D module to resolve any ambiguities. Heart morphology for all samples was initially assessed by the same operator, with classification of heart defects confirmed by an independent observer. Samples with ventricular septal defects (VSD) were further classified as double-outlet right ventricle (DORV) if on a frontal section the aorta was positioned wholly to the right of the ventricular septum (VS), and as overriding aorta if the aorta was positioned equally over both ventricles.
Quantitative PCR
Genomic DNA was isolated from E9.5 heart tissue, and qPCR performed using TaqMan s probes for Hif1α (Custom Plus Assay designed to detect both Hif1α wild type and Hif1α flox alleles) and β-actin (Mm02619580_g1). Assays were performed in triplicate and a standard curve was generated using embryonic hearts from Cre-negative embryos.
For transcript analysis, E9.5 embryo hearts were isolated, mRNA extracted (PureLink™ kit with DNaseI treatment, Invitrogen), and reverse transcribed (SuperScript s VILO™ cDNA synthesis kit, Invitrogen). Transcript levels were determined using the following TaqMan s gene expression assays (Applied Biosystems): Hif1α (Mm01283757_m1), β-actin (Mm01205647_g1), Tbx5 (Mm00803518_m1) and Nkx2-5 (Mm00657783_m1). Assays were performed in triplicate with FAM-labeled test probe and VIClabeled β-actin probe as an internal control. Reactions were done using Lightcycler s 480 Probes Master (Roche Applied Science), and were run on a Roche Lightcycler s 480 (Roche Applied Science).
Maternal low oxygen exposure
Dams were exposed to varying levels of reduced oxygen at normal atmospheric pressure for 8 h at E9.5 as previously described (Sparrow et al., 2012) .
Quantification of embryonic levels of hypoxia
Wild-type C57BL/6J dams were injected peritoneally with hypoxyprobe™ (pimonidazole hydrochloride, Hypoxyprobe Inc.) at 60 mg/kg prior to 3 h of maternal low oxygen exposure. Embryos (E9.5) and embryonic tissues (E12.5) were collected and frozen prior to whole cell protein extraction and western blotting using FITC-conjugated IgG1 monoclonal antibody (Hypoxyprobe Inc.) and Rabbit anti-FITC HRP antibody (Hypoxyprobe Inc.) as previously described (Sparrow et al., 2009) . The β-tubulin loading control was quantified using a goat anti-β-tubulin antibody (T5201, Sigma-Aldrich) and a donkey anti-goat AlexaFluor™ 680 secondary antibody (Jackson ImmunoResearch).
Immunostaining and mitotic index determination
HIF1α expression was analyzed by immunofluorescence in either wholemount or on wax sections using an anti-HIF1α antibody (NB100-449, Novus Biologicals) and a donkey anti-rabbit Cy3 secondary antibody (Jackson ImmunoResearch) as previously described (Geffers et al., 2007) . Nuclei were counterstained with TO-PRO3 (Life Technologies). Images were captured on a LSM 710 confocal microscope (Carl Zeiss Microscopy). Myocardial proliferation was assessed by wholemount immunofluorescence using an anti-phospho-Histone H3 (Ser10) antibody (06-570, Merck Millipore) and a donkey anti-rabbit Cy3 antibody (Jackson ImmunoResearch). Nuclei were counterstained with DAPI. A z series of optical sections 1.5 mm apart encompassing the entire heart were captured. Every 20th optical section, a total of 4-7 sections per heart, was analyzed using ImageJ software (NIH) and the mean mitotic index calculated. This was expressed as the percentage of phospho-Histone H3 positive area per total myocardial area.
Statistical analyses
Statistical analyses were performed using Microsoft Excel and Prism 6 (GraphPad Software Inc). Statistical significance of embryo survival across genotype groups was tested by Chi-squared test. For statistical analysis of weights, embryo and placenta weights from Hif1α deleted samples (Hif1α Δ/flox Cre þ / À ) were normalized against the averaged weights of control littermates, and the normalized weights for each genotype group were analyzed using Student's ttest. Significance in the heart defect prevalence between genotype groups was tested using one-tailed Fisher's exact test. Significance of qPCR, western blots and mitotic index were tested using Student's t-test. Where the data were bounded by zero (RT qPCR), the data were transformed using natural logarithms to correct for right-skew prior to analysis by Student's t-test.
Results
Deletion of Hif1α from mesoderm leads to heart defects and embryo lethality
Complete deletion of Hif1α from the mouse conceptus results in extensive placental, vascular and heart defects, resulting in embryonic lethality by embryonic day (E) 10.5 (Compernolle et al., 2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998) . Therefore it is difficult to identify where Hif1α specifically functions during development. We used conditional deletion to directly address this issue. We first conditionally deleted Hif1α from mesoderm using the MesP1 Cre allele. This allele is expressed in embryonic and extra-embryonic mesoderm from E6.5 (Saga et al., 1999) and therefore deletes DNA in a broad range of mesoderm in both the embryo, including the heart and vasculature, as well as in the placenta. We crossed Hif1α Δ/ þ MesP1 Cre þ / À males with Hif1α flox/flox females and collected embryos and placentas at E17.5 (when heart development is essentially complete). As a comparison, we intercrossed Hif1α Δ/+ mice, and collected embryos and placentas at E17.5. As expected from previous studies, complete deletion of Hif1α results in 100% embryo lethality by E17.5 (Fig. 1A) , by contrast, deletion of Hif1α from mesoderm led to $ 55% embryo lethality ( Fig. 1A ; Table S1 ). Surviving conditionally-deleted embryos were significantly lighter than their control littermates ( Fig. S1 ). Analysis of heart morphology at E17.5 identified a significantly increased prevalence of heart defects in conditionally-deleted embryos (6/17 compared with 1/28 of controls analyzed; Fig. 1B ; Table S1 ; Fig. S1A , defective embryos indicated in red). The heart defects in the conditionally deleted embryos included ventricular septal defect (VSD), overriding aorta (OA) and ectopia cordis (EC) ( Fig. 2 ; Table S1 ). In summary, Hif1α is required in mesoderm for survival and for normal development of the heart. Its absence from mesoderm leads to $ 55% embryo lethality, and 35% of surviving conditionallydeleted embryos develop heart defects ( Fig. 1A and B ).
Deletion of Hif1α from vascular endothelial cells impacts on development of the placenta and embryo
Deletion of Hif1α from mesoderm resulted in significant heart defects and embryonic lethality. The mesoderm gives rise to both the vasculature (embryonic and placental) and the heart, and we considered that expression of Hif1α in either or both of these tissues might be important for causing heart defects and/or lethality. We first sought to determine if the observed defects were caused by loss of Hif1α in the vasculature alone. We therefore conditionally deleted Hif1α from vascular endothelial cells (VECs) and hematopoietic cells using the Tek-Cre transgene (Constien et al., 2001; Tang et al., 2004) . This transgene drives expression of Cre recombinase in all VECs from E7.5 (Koni et al., 2001) in both embryonic and extra-embryonic vessels, including those of the yolk sac and placenta. In the heart, Tek-Cre is expressed in the endocardium, the myocardial vasculature, the mesenchymal cells of the proximal outflow tract, the atrioventricular canal and in the developing leaflets of the pulmonary and aortic valves (Kisanuki et al., 2001; Schlaeger et al., 1997) . We crossed Hif1α Δ/ þ Tek-Cre þ males with Hif1α flox/flox females and collected embryos and placentas at E17.5. Deletion of Hif1α from VECs had no affect on embryo survival (Table S2) , although both embryos and placentas were significantly lighter than controls ( Fig. S2 ). Vascular defects such as hemorrhage or edema were not apparent in embryos. Analysis of heart morphology at E17.5 identified heart defects in 15% of conditionally-deleted embryos (2/13 compared with 0/10 of controls analyzed; Table S2 ; Fig. S2 , defective embryos indicated in red). However the prevalence of heart defects in these embryos was not significantly increased over controls. The heart defects were VSD with OA or doubleoutlet right ventricle (DORV) ( Table S2 ; Fig. 2) . Notably, the embryos with heart defects were significantly lighter than the other embryos of the same genotype (Fig. S2A ). In summary, Hif1α is required in the vasculature of the yolk sac, placenta and/or embryo for normal embryo and placental growth, and its loss in VECs may contribute to a low prevalence of heart defects.
Deletion of Hif1α from cardiac precursor cells results in reduced placental and embryo weight, and may impact heart development
Since the majority of heart defects and embryonic lethality caused by the loss of Hif1α in mesoderm did not appear to be due to a requirement for Hif1α in VECs, we next sought to conditionally delete Hif1α from cardiac precursors and derivatives using the Nkx2-5 IRESCre allele. This allele is expressed in the first and second heart fields from E7.75, with recombinase activity evident throughout the myocardium as development proceeds (Stanley et al., 2002) . Later in development, this allele is also expressed in a number of extra-cardiac regions, including derivatives of the pharyngeal floor and foregut endoderm including the lung epithelium, and parts of the liver, thyroid, spleen, pancreas and stomach (Stanley et al., 2002) . We crossed Hif1α Δ/ þ Nkx2-5 IRESCre þ / À males with Hif1α flox/flox females and collected embryos and placentas at E17.5. Deletion of Hif1α from the heart did not affect embryo survival ( Fig. 1A ; Table S3 ), but these embryos and their placentas were significantly lighter than controls (Fig. S3 ). Analysis of heart morphology revealed that 14% of these embryos had heart defects (3/21 embryos with VSD, OA, DORV, straddling and overriding tricuspid valve (SOTV); Fig. 1B; Fig. S3 , defective embryos indicated in red). However, 2/55 controls also had heart defects (VSD with OA), therefore this was not a significantly increased prevalence. In summary, Hif1α expression in the heart is required for normal embryo and placenta growth, and its absence from the heart during development may contribute to a low prevalence of heart defects.
Hif1α is deleted from the heart using MesP1 Cre or Nkx2-5 IRESCre
Although deletion of Hif1α from all embryonic and extraembryonic tissues causes completely penetrant heart defects and embryo lethality (Compernolle et al., 2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998) , in our study where Hif1α is essentially deleted from the mesoderm (MesP1 Cre ) or the heart (Nkx2-5 IRESCre ), we observed a much reduced prevalence of lethality and heart defects. This disparity might be due to incomplete deletion of the floxed Hif1α allele in our system. We therefore investigated the extent of Hif1α deletion from the heart for both Cre alleles. First we used qPCR to determine the copy number of the wild-type Hif1α allele in genomic DNA from E9.5 mouse hearts of each of the four genotypes resulting from Hif1α Δ/+ Cre þ / À by Hif1α flox/flox crosses.
We used β-actin (2 copies) as an internal control. Deletion by both MesP1 Cre and Nkx2-5 IRESCre resulted in approximately the expected Hif1α copy number in each genotype (Fig. 3A and B ). This suggests that both Cre alleles efficiently deleted Hif1α DNA by E9.5. Despite efficient deletion at the genomic level, it is possible that Hif1α transcripts perdure in the cell after genomic deletion. To test if this was the case, we isolated poly A þ RNA from E9.5 mouse hearts of each of the four genotypes resulting from Hif1α Δ/ þ Cre þ / À by Hif1α flox/flox crosses, and used qRT-PCR to determine the abundance of Hif1α transcripts, relative to an internal control (β-actin). Deletion by either MesP1 Cre or Nkx2-5 IRESCre resulted in an almost total absence of Hif1α transcripts in the Hif1α Δ/flox Cre þ / À genotype compared with all 3 other groups ( Fig. 3C and D) .
In conclusion, Hif1α DNA was essentially deleted in hearts of Hif1α Δ/flox Cre þ / À embryos by E9.5, and virtually no transcripts of this gene remained at this stage.
Exposure of MesP1 Cre conditionally-deleted embryos to short-term hypoxia reduces embryo survival
In our system, Cre-mediated mesoderm-or cardiac-specific deletion of Hif1α did not generate the same severe heart phenotype as the complete null (Compernolle et al., 2003; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998) . The Hif1α complete null embryos differ from our mesoderm-or cardiac-specific deleted embryos because they are associated with placental insufficiency (Cowden Dahl et al., 2005) . We have shown that relatively mild defects in placenta formation causes placental insufficiency, resulting in elevated cellular hypoxia in mouse embryos (Sparrow et al., 2009) . Complete deletion of Hif1α essentially prevents the placenta from forming, resulting in non-physiological hypoxia in embryos (Ryan et al., 1998) . In such embryos, the expected increase in requirement of HIF1α may lead to defects in tissues lacking this gene. We hypothesized that subjecting the Hif1α conditional null embryos to increased hypoxic stress might exacerbate the prevalence or severity of heart defects. To test this hypothesis, we used our method of exposing pregnant mice to an atmosphere with reduced oxygen concentration at normal pressure for 8 h at E9.5 (Sparrow et al., 2012) . Whilst this induces short-term embryonic hypoxia, it is unlikely to match the placental insufficiency that likely occurs over a number of days in Hif1α nulls; nevertheless it is sufficient to increase the severity and penetrance of vertebral defects in genetically-susceptible embryos (Sparrow et al., 2012) . We investigated the effects of maternal low oxygen exposure on embryos with Hif1α deleted from mesoderm using the MesP1 Cre allele. Crosses were performed as above, then pregnant mice were exposed to an atmosphere with reduced oxygen for 8 h at E9.5. After exposure, pregnant mice were returned to normoxia and the embryos allowed to develop until harvest at E17.5. Embryo and placenta weights were recorded, and heart morphology determined as above. We commenced with 7% oxygen as this level of maternal exposure does not impact on the survival of wild-type embryos (Sparrow et al., 2012) . The combination of exposing pregnant mice to 7% oxygen and a lack of Hif1α in embryonic mesoderm significantly increased embryonic lethality ( $ 91%) compared with unexposed embryos of the same genotype ( $ 55%; Fig. 4A ). This strongly suggests that there was a significant Gene-environment interaction in this system. In addition, surviving embryos were significantly lighter than exposed controls (Fig. S4A ). Litters exposed to 8% oxygen showed similar results ( Fig. 4A; Fig. S4B ). In both cases only about 9-13% of embryos lacking Hif1α in mesoderm survived, and collectively 4/5 had major heart defects ( Fig. 4B ; Tables S4 and S5 ). Since virtually all embryos that lacked Hif1α in mesoderm died following maternal exposure to 7-8% oxygen, we were unable to determine if those that survived had a significantly increased prevalence of heart defects compared to non-exposed conditionally deleted embryos. To further investigate this point, we next exposed pregnant mice to 12% oxygen for 8 h at E9.5 and analyzed them as above. At this level of maternal exposure embryo lethality was not increased over that observed under normoxia (Fig. 4A ). Embryos were significantly lighter than exposed controls (Fig. S4C ). Analysis of heart morphology revealed a slight but non-significant increase in the prevalence of heart defects in embryos lacking Hif1α in mesoderm comparing maternal exposure to 12% oxygen or normoxia (9/17 compared with 6/17; Fig. 4B ; Tables S1 and S6). Taken together, these data demonstrate that maternal exposure to lowered oxygen levels significantly increases the prevalence of lethality in embryos lacking Hif1α in mesoderm. Interestingly, maternal exposure at 7-8% oxygen resulted in an almost completely penetrant embryonic lethality ($89%; Fig. 4A ), similar to the fully penetrant lethality reported for Hif1α complete null embryos. This suggests that maternal exposure to short-term hypoxia can in part replicate the non-physiological hypoxia generated by placental insufficiency occurring in complete Hif1α null embryos.
Exposure of Nkx2-5 IRESCre conditionally-deleted embryos to shortterm hypoxia reduces embryo survival
Having demonstrated an increased requirement for Hif1α in embryonic mesoderm under hypoxic conditions, we next sought to determine if a lack of Hif1α in the heart alone could be sufficient to impair embryo survival and/or heart development under such conditions. We investigated the effects of maternal low oxygen exposure on embryos with Hif1α deleted from the heart using the Nkx2-5 IRESCre allele. Crosses were performed as above, pregnant mice were exposed to an atmosphere with reduced oxygen for 8 h at E9.5, returned to normoxia, and the embryos allowed to develop until E17.5 before harvest. Embryo and placenta weights were recorded, and heart morphology determined as above. In the MesP1 Cre experiments described above, there was no observed difference between the phenotypes of embryos whose mothers were exposed to 7% or 8% oxygen. Therefore we used the higher oxygen concentration for the Nkx2-5 IRESCre experiments. The combination of exposing pregnant mice to 8% oxygen and a lack of Hif1α in the embryonic heart significantly reduced embryo survival ( $64%) compared with unexposed embryos ( $ 9%; Fig. 4C ). In addition, surviving embryos were significantly lighter than exposed controls (Fig. S5A ). Analysis of heart morphology showed a slight but non-significant increase in the prevalence of heart defects in embryos lacking Hif1α in the heart between 8% oxygen and normoxia (2/9 compared with 3/21; Fig. 4D ; Tables S3 and S7) . Similarly, maternal exposure to 9% oxygen also significantly reduced the survival of embryos lacking Hif1α in the heart ( $77%) compared with embryos of the same genotype exposed to normoxia ( $ 9% lethality; Fig. 4C ). In addition, surviving embryos were significantly lighter than exposed controls (Fig. S5B) . Analysis of heart morphology showed a small but non-significant increase in the prevalence of heart defects in embryos lacking Hif1α in the heart at 9% oxygen and normoxia (2/6 compared with 3/21; Fig. 4D ; Tables S3 and S8). Given that exposing embryos lacking Hif1α in the heart to 8-9% oxygen profoundly affected lethality, we exposed pregnant mice carrying such embryos to 12% oxygen for 8 h at E9.5 and analyzed them as above. In embryos lacking Hif1α in the heart, maternal exposure to 12% oxygen did not affect survival (Fig. 4C) , nor did it affect the prevalence of heart defects compared with normoxia (5/32 compared with 3/21; Fig. 4D ; Tables S3 and S9 ). Surviving embryos were significantly lighter than exposed controls (Fig. S5C) . Taken together, these data demonstrate that maternal exposure to lowered oxygen levels significantly increases the prevalence of embryonic lethality, and may also increase the prevalence of heart defects in embryos lacking Hif1α in the heart.
Maternal exposure at 8-9% oxygen, a level of oxygen that does not adversely impact the survival of control embryos, resulted in $ 64-77% lethality of embryos lacking Hif1α in the heart. In addition, heart defects were observed in 22-33% of surviving conditionally deleted embryos ( Fig. 4C and D) . To further investigate the timing of lethality, we repeated the crosses described above. Pregnant mice were exposed to 9% oxygen for 8 h, then returned to normoxia prior to embryo collection at E10.5. Control mice were maintained in normoxic conditions until embryo harvest at E10.5. At this stage, embryos of all genotypes were present in equal numbers, but there was a significantly increased prevalence of abnormality in conditionally deleted embryos exposed to 9% oxygen compared with normoxia (11/18 compared Fig. 4 . Embryonic survival and prevalence of heart defects following embryonic Hif1α deletion and maternal exposure to lowered oxygen levels. (A, C) Histograms showing the estimated percentage of embryos that survived until E17.5 following embryonic Hif1α deletion in mesoderm (A) or cardiac progenitor cells (C) with maternal exposure to the indicated level of oxygen for 8 h on E9.5. Normoxia (21% oxygen) represents the unexposed control. The statistical significance of the deviation of the numbers of surviving embryos for each of the four genotypes from the expected 1:1:1:1 Mendelian ratio was calculated using chi-squared tests. (B, D) Histograms showing the percentage of heart defects present in surviving E17.5 embryos that were analyzed for heart morphology following embryonic Hif1α deletion in mesoderm (B) or cardiac progenitor cells (D) with maternal exposure to the indicated oxygen level. C represents pooled embryos from all three control genotypes, and Hf/HΔ Cre þ represents conditionally deleted embryos. with 1/17; Tables S10 and S11). At 9% oxygen, 2/18 of these embryos were very small and were necrotic; 9/18 were smaller than littermates and 6 of these also had an enlarged pericardial sac (data not shown). However, despite these defects all of the nonnecrotic embryos (9/18) had normal heart morphology, with correct looping and normal chamber morphology (data not shown). This suggests that embryos lacking Hif1α in the heart are very vulnerable to in utero exposure to lowered oxygen levels, and such exposure rapidly triggers embryonic lethality.
Short-term exposure of pregnant mice to low oxygen increases embryonic hypoxia and stabilization of HIF1α in the heart To investigate the molecular consequences of short-term low oxygen exposure in embryos, we examined cellular hypoxia and the response of HIF1α protein in embryos immediately following such exposure. Firstly, we used hypoxyprobe™ (pimonidazole hydrochloride) to measure cellular hypoxia in embryos. Hypoxyp-robe™ is reductively activated, forming adducts with thiol groups in cells experiencing r 2% oxygen (Mahy et al., 2003; Raleigh et al., 1999) . These adducts can be detected using a specific antibody (Kennedy et al., 1997) . To assess the relative levels of cellular hypoxia in exposed and unexposed embryos, we injected pregnant mice with hypoxyprobe™ at E9.5, exposed them to 8% oxygen for 3 h (whilst control mice remained at normoxia), then harvested the embryos and quantified the hypoxia using western blotting as previously described (Sparrow et al., 2009) . Cellular hypoxia was dramatically increased in exposed embryos ( Fig. 5A and B) . Secondly, we compared HIF1α protein levels in exposed and control embryos in vivo using wholemount immufluorescence. Hif1α is constitutively transcribed and translated in cells, but under normoxic conditions the HIF1α protein has an extremely short half-life of less than 5 min (Huang et al., 1996; Yu et al., 1998) . Under hypoxic conditions HIF1α is stabilized and rapidly accumulates in the nucleus, activating its target genes (Kallio et al., 1998 ). We exposed pregnant mice to 9% oxygen for 3 or 8 h at E9.5 (whilst control mice remained at normoxia), then harvested the embryos and performed immunofluorescence in wholemount. Nuclear HIF1α was not detected in any region of control embryos (Fig. 5D -F) or those exposed for 3 h (not shown), whereas embryos exposed for 8 h had readily detectable levels of nuclear HIF1α specifically localized in the myocardium (Fig. 5G-I) . To determine if this result reflected an intrinsic susceptibility of myocardium to hypoxia, we next examined the localization of HIF1α under increased hypoxic stress. We exposed wild type embryos to the lowest possible oxygen level (5.5% oxygen for 8 h, Sparrow et al., 2012) , and used immunofluorescence to detect HIF1α protein (Fig. S6 ). In these embryos, nuclear HIF1α was once again detected in the myocardium (Fig. S6F ) and also in gut epithelium (data not shown). Low level nuclear accumulation was also detectable in forebrain epithelium (Fig. S6H) . Taken together, these data demonstrate that short-term maternal exposure to mildly lowered oxygen levels (9%) at E9.5 is sufficient to cause cellular hypoxia in the embryos by 3 h, and localization of HIF1α protein to the nucleus of embryonic myocardial cells by 8 h. Furthermore, the vast majority of HIF1α protein accumulation was in myocardial cells, suggesting that this tissue is likely to be much more susceptible to non-physiological hypoxia than the other tissues of the developing embryo.
Myocardial proliferation is reduced in hearts lacking Hif1α
Short-term exposure of embryos in utero to reduced oxygen levels caused accumulation of HIF1α protein in the nucleus of the myocardium. Additionally, it caused rapid demise of embryos that were unable to respond to this hypoxic insult due to the lack of Hif1α in the heart. As embryo death did not appear to be due to a disruption of gross heart morphology, we next examined the cellular response of myocardium lacking Hif1α to cellular hypoxia. In particular, we investigated cell proliferation and cell death. We exposed pregnant mice to 9% oxygen for 8 h at E9.5 (whilst control mice remained at normoxia), and then harvested the embryos immediately after maternal exposure. To examine proliferation, these embryos were co-stained with an antibody for phosphorylated Histone H3 and the nuclear marker DAPI, and the myocardial mitotic index calculated (Fig. 6 ). Embryos lacking Hif1α in the heart showed a significant drop in the myocardial mitotic index compared with control genotypes. This drop occurred regardless of whether or not their mothers had been exposed to reduced oxygen levels. By contrast, for both wild type embryos and embryos lacking Hif1α in the heart, maternal exposure to 9% oxygen did not cause significantly reduced myocardial proliferation compared with unexposed embryos (Fig. 6F ). To examine cell death, embryos generated as described above were stained with LysoTracker Red (Life Technologies) . Surprisingly, staining was completely absent from the heart, despite being present elsewhere in the embryo, regardless of genotype or oxygen concentration (data not shown). These data demonstrate that myocardial proliferation is significantly reduced in hearts lacking Hif1α compared with controls, but that maternal exposure to reduced oxygen levels does not alter embryonic myocardial cell proliferation or cell death. Therefore the hypoxia-induced death of embryos lacking cardiac Hif1α is not due to a lack of cellular proliferation in the heart, or to an increase in cell death.
Discussion
Hif1α deletion from the mouse conceptus leads to completely penetrant embryonic lethality by E10 due to a collapse in the development of the cardiovascular system of the embryo, yolksac and placenta (Compernolle et al., 2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998) . These studies have shown that Hif1α is required for normal development, but they do not specifically identify the tissues in which Hif1α functions, or if Hif1α is actually required in the embryo when the placenta is functioning (which is not the case in the complete Hif1α null). We have addressed these issues by conditionally deleting Hif1α from specific cell types and tissues, resulting in a number of key findings. Most significantly, we demonstrate that Hif1α is not required for development of the cardiovascular system when the embryo develops in the context of a functioning placenta. Additionally, we find that Hif1α is primarily required in the heart when the embryo is exposed to lowered oxygen conditions.
Firstly, we showed that Hif1α is not required in VECs of the embryo, yolksac or placenta for either normal morphological development or for embryo survival, using conditional deletion with Tek-Cre. However there was an impact on embryo and placental growth, and a slight but non-significant increase in the prevalence of heart defects. This lack of lethality might have been predicted as progeny of a Hif1α flox/flox Â Tek-Cre intercross survive to adulthood (Tang et al., 2004) . However in that study, an embryonic phenotype may have been averted due to incomplete conditional deletion of Hif1α throughout the conceptus during development. Others have reported incomplete Hif1α deletion when using homozygous Hif1α flox alleles (Krishnan et al., 2008; Mason et al., 2004) . By contrast, our study design maximized Hif1α deletion in VECs by using Hif1α Δ/flox embryos that only require
Tek-Cre to act on a single Hif1α flox allele. Our finding that Hif1α is not overtly required in VECs during development is intriguing, as Hif1α is required for angiogenesis during wound healing and tumorigenesis in adult mice (Tang et al., 2004) . Our results suggest that embryonic and adult angiogenesis is different; this may reflect differences in the ability of tissues surrounding the VECs to respond to VEC-mediated HIF1α-induced signals. In support of our findings, Imanirad et al. (2013) have very recently reported that deletion of Hif1α from VECs using another Cre-expressing transgene, also does not affect embryo development or survival.
In contrast to deletion of Hif1α from trophoblasts or VECs, deletion of Hif1α from a broad range of mesoderm using the MesP1 Cre allele caused significant embryo death and significantly increased the prevalence of heart defects. To more specifically define in which mesodermal tissues Hif1α functions, we used the Nkx2-5 IRESCre allele to delete Hif1α within a more restricted embryonic domain, the heart. We found that Hif1α is not specifically required in the heart for normal morphological development or embryo survival. As with deletion of Hif1α in VECs, there was an impact on embryo and placenta growth and an increased, but non-significant, prevalence of heart defects. These findings are in contrast with previous work where Hif1α was deleted using MLC2v-Cre (Krishnan et al., 2008) . In that study, heart development arrested with myocardial hyperplasia at E10, and lethality occurred by E11-12. It is difficult to reconcile this severe phenotype with the mild one we observe since MLC2v-Cre is expressed later in development and is also expressed in a much more restricted pattern (first heart field and derivatives) than Nkx2-5 IRESCre (first and second heart fields and derivatives, Chen et al., 1998; Li et al., 2011; Stanley et al., 2002) . In addition, our study had a more complete deletion of Hif1α: Krishnan et al. (2008) show that Hif1α mRNA levels in their system are reduced by only 35-80% in Hif1α Δ/flox ; MLC2v-Cre hearts at E8.75-9.25, while we showed complete absence of Hif1α genomic DNA and mRNA in Hif1α Δ/flox ; Nkx2-5 IRESCre þ / À hearts at E9.5. One explanation for the different phenotypes observed in these two studies is that each used a different Hif1α null allele (Dunwoodie, 2009 ). Krishnan et al. (2008) used a Hif1α null allele that causes myocardial hyperplasia in homozygous Hif1α null embryos (Iyer et al., 1998) . This null allele contains an active PGK promoter driving expression of the neo gene. The Hif1α null allele used in our study does not contain PGK-neo, and does not cause myocardial hyperplasia (Ryan et al., 1998) . A third Hif1α allele exists that also lacks myocardial hyperplasia (Compernolle et al., 2003) . It is therefore possible that the myocardial hyperplasia and embryonic lethality reported by Krishnan et al. (2008) stems from the particular Hif1α null allele used, rather than the loss of Hif1α in the myocardium per se (Dunwoodie, 2009) . It is also possible that the genetic background of the mice used in the different studies has bearing on the phenotype. Our study used C57BL/6J mice ( 410 backcrosses) whilst Krishnan et al. (2008) used mice of mixed background (C57BL/6; 129SvJ; 129S1). Our final finding may have clinical relevance. It concerns the hitherto unappreciated vulnerability of the developing heart to hypoxia. In order to recapitulate the gestational environment of the Hif1α homozygous null conceptus (Compernolle et al., 2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998 ), we exposed pregnant female mice carrying embryos lacking Hif1α in the heart to short-term lowered oxygen levels so as to mimic the embryonic hypoxia experienced by these complete Hif1α nulls due to lack of placental function. We showed that the majority of embryos lacking Hif1α in the heart died following such exposure. Embryo death did not appear to result from a disruption of heart morphology, nor from an increase in cell death or decrease in cellular proliferation. These data provide compelling evidence that the lethality seen in complete Hif1α null embryos occurs because the heart fails if it does not have Hif1α to respond to the non-physiological hypoxia caused by placental insufficiency. Our study demonstrates the vulnerability of the heart to lowered levels of oxygen, as under such hypoxic conditions the embryo absolutely requires Hif1α in the heart to survive. We discovered that this is a heart-specific phenomenon, at least at E9.5-10.5, as we showed that HIF1α accumulated predominantly in the myocardium of embryos exposed to either a mild or severe reduction in oxygen. Consideration of the physiology of the developing heart, a uniquely active tissue in the embryo, suggests a possible mechanism for the embryonic lethality in the absence of structural heart defects. The energetic needs of the post implantation mouse embryo (E5.6-E6.5) are almost entirely met in this low oxygen environment by glycolysis (Wales et al., 1995) . As development proceeds, the proportion of energy derived from glucose oxidation increases with the increasing vascularization of the embryo. However at E9.5 oxidative phosphorylation is still a minor contributor (Folmes et al., 2012a (Folmes et al., , 2012b Wales et al., 1995) . At this stage cardiomyocytes have only a few fragmented mitochondria with poorly defined and organized cristae, and so are primarily dependent on anaerobic glycolysis for ATP generation, as is the rest of the embryo (Hom et al., 2011; Wales et al., 1995) . Extensive growth is a feature of subsequent embryonic development (E9.5-13.5). Such growth can only be sustained with elevated cardiac output, and the increasing bioenergetic demands of the cardiomyocytes require efficient oxidative ATP generation. Networks of elongated and branched mitochondria with abundant organized cristae are a feature of cardiomyocytes at E13.5 (Hom et al., 2011) . Thus between E9.5 and E13.5 is a critical time for the embryo as cardiomyocytes transition between anaerobic and aerobic glycolysis. This transition needs to be balanced against the increasing cardiovascular requirements of the rapidly growing embryo. Clearly an adequate oxygen supply is crucial for this transition and for sustaining embryonic growth and viability. Thus it might be predicted that when we expose embryos to lowered oxygen levels at E9.5 for 8 h, we disrupt this critical balance between embryonic growth demands, contractility of the myocardium, ATP requirement and oxygen. Such a disruption is clearly seen in the accumulation of nuclear HIF1α in the myocardium, indicating that there is insufficient oxygen to sustain the metabolic activity of the cardiomyocytes. However in the absence of Hif1α, the effects of hypoxia cannot be redressed by the normal compensatory mechanisms co-ordinated by HIF1α. Failure of these compensatory mechanisms then rapidly results in significant embryonic lethality.
Our discovery that the heart is extremely vulnerable to reduced levels of oxygen is potentially clinically relevant for two reasons. Firstly, during embryonic development, short-term exposure to low oxygen causes cellular hypoxia of the myocardium. This, coupled with a genetic predisposition that impairs any of the systems that deliver, monitor and/or respond to oxygen, or are required for cardiomyocyte contractile function, or mitochondria and energy metabolism, may lead to death in utero. Secondly, in cases of congenital heart disease where chronic underperformance of the cardiovascular system occurs even post-surgery, such as in hyperplastic left heart syndrome, an impaired response to cardiomyocyte hypoxia (Gaber et al., 2013) may explain the variable outcomes experienced by these patients. In conclusion, our Hif1αcentered studies shed light on these clinical situations and may in time lead to identification of individuals at increased risk of death in utero or after cardiac surgery, and to the development of preventative therapies.
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